Ned Whittemore, Ph.D.
Ned Whittemore, PhD is Director of Regulatory Affairs, Quality Assurance and the Preclinical Development Consortium. He manages all regulatory activities, including regulatory operations, submissions and strategic planning. In addition to paper submissions, Dr. Whittemore has experience in electronic common technical document (eCTD) submissions. Dr. Whittemore also oversees the Preclinical Development Consortium (PDC) and the firm’s quality assurance activities, including internal audits and compliance audits of external vendors.
Dr. Whittemore has 19 years of biopharmaceutical industry experience that includes productive drug discovery research and regulatory affairs positions with Xytis, Inc., where he was Senior Director, Ion Channels. Previously he served as Group Leader of Ion Channels at Vertex Pharmaceuticals; Group Leader of In Vitro Pharmacology at Purdue Pharma; Group Leader of Electrophysiology/In Vitro Pharmacology at CoCensys, Inc.; and a Research Specialist at the University of California-Irvine. His work has focused on the therapeutic areas of pain, anxiety, cognition, stroke and Parkinson’s disease.
Dr. Whittemore earned his MS and PhD in Biochemistry from the University of Minnesota, as well as his BA in Biology from Carleton College. He, like Dr. Louise M. Murphy, recently earned his Certified Quality Auditor (CQA) certification from the American Society for Quality.